Your browser doesn't support javascript.
loading
Re: Minimizing risks to patients by improving presentation of clinical trial results in geographic atrophy trials (Ophthalmol Retina. 2022;6:337-338).
Liao, David S; Grossi, Federico V; Wykoff, Charles C; Ribeiro, Ramiro M; Rosenfeld, Philip J; Sadda, Srinivas R.
Affiliation
  • Liao DS; Retina-Vitreous Associates Medical Group, Los Angeles, California. Electronic address: dliao@laretina.com.
  • Grossi FV; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Wykoff CC; Retina Consultants of Texas, Houston, Texas.
  • Ribeiro RM; Apellis Pharmaceuticals, Inc, Waltham, Massachusetts.
  • Rosenfeld PJ; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.
  • Sadda SR; Department of Ophthalmology, University of California - Los Angeles, Los Angeles, California; Doheny Eye Institute, Pasadena, California.
Ophthalmol Retina ; 6(11): 1109, 2022 11.
Article in En | MEDLINE | ID: mdl-36334931
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Geographic Atrophy Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ophthalmol Retina Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Geographic Atrophy Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ophthalmol Retina Year: 2022 Document type: Article Country of publication: United States